BridgeMD
New treatment option for Postnatal Depression
Official title New Cognitive Treatment for Peripartum Depression
ClinicalTrials.gov ID: NCT06253390
What this study is testing
- What it's testing
- The peripartum period is the period between the last month of pregnancy and up to a year after childbirth. It can be considered a difficult time for women, as it is a period of transition during which vulnerability to psychiatric disorders and in particular to major depressive disorder (MDD) (Vesga-Lopez, Blanco, Olfson, Grant \& Hasin, 2008).
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Women over 18 years
- Meets the diagnostic criteria for depressive disorder with peripartum onset (PPD) (APA, 2013) and has already given birth
- EPDS score over 10
- Have given their consent to take part in the study
- Be affiliated to a social security system
You likely can't join if
- \- Be the subject of a protection measure
- Being a minor
- Meets the diagnostic criteria for schizophrenia spectrum disorders (brief psychotic disorder; schizophrenic disorder; schizoaffective disorder...
- Meet the criteria for substance abuse or dependence (alcohol, drugs)
- With insufficient command of the French language
- People with a deceased child
See the full eligibility criteria
- Women over 18 years
- Meets the diagnostic criteria for depressive disorder with peripartum onset (PPD) (APA, 2013) and has already given birth
- EPDS score over 10
- Have given their consent to take part in the study
- Be affiliated to a social security system
- Have an adequate knowledge of written, understood and spoken French (French mother tongue or primary education in the French education system) All women with PPD, whether breastfeeding or not, can be included in the...
- \- Be the subject of a protection measure
- Being a minor
- Meets the diagnostic criteria for schizophrenia spectrum disorders (brief psychotic disorder; schizophrenic disorder; schizoaffective disorder; delusional disorder; brief psychotic disorder with peripartum onset)
- Meet the criteria for substance abuse or dependence (alcohol, drugs)
- With insufficient command of the French language
- People with a deceased child
- People who do not meet the diagnostic criteria for depressive disorder with peripartum onset (APA, 2013)
- People who do not agree to take part in the study
The study team makes the final eligibility decision.
Where it's taking place
- Reims, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.